page 74 

-

the manufacturing process for goods;
the suitability of goods or services for a specific use;
the quality, quantity or other characteristic of goods or services;
the conditions on which goods or services are offered or supplied;
the price of goods or services or the mode of calculation.

Section 5: Unfair competition concerning confidential information
Article 371: Any act or practice which, in the course of industrial or commercial activities,
entails the disclosure, acquisition or use by third parties of confidential
information without the consent of the person who is legally entitled to dispose
of such information, who is the legitimate holder and in a way contrary to honest
business practices, shall constitute an act of unfair competition.
Article 372: The disclosure, acquisition or use of confidential information by third parties
without the consent of the legitimate holder may, in particular, arise from the
following acts:
-

industrial or commercial espionage;
breach of contract;
breach of trust;
incitation to commit industrial or commercial espionage, breach of contract or
breach of trust;
- acquisition of confidential information by a third party who was aware that
this acquisition entailed one of the foregoing acts or whose ignorance in this
regard stemmed from gross negligence.

Article 373: Within the meaning of this Section, information shall be considered confidential
if:
- it is not, in its entirety or in the exact configuration and assembly of its
elements, widely known to persons belonging to circles which generally deal
with the type of information in question or is not easily available to them;
- it has commercial value because it is confidential;
- its legitimate holder has taken reasonable steps, given the circumstances, to
keep it confidential.
Article 374: Any act or practice which, in the course of industrial or commercial activities,
constitutes or entails the following, shall be deemed an act of unfair competition:
- unfair exploitation in trade of confidential data resulting from trials or other
confidential data, whose establishment requires considerable effort and which
have been communicated to a competent authority with a view to obtaining
authorization to commercialize pharmaceutical products or agrochemical
products which involve new chemical entities;

Select target paragraph3